Publication Information

{'id': 'https://openalex.org/W2258666746', 'doi': None, 'title': 'Inferences on the nature of the apical sodium entry site in frog skin epithelium.', 'display_name': 'Inferences on the nature of the apical sodium entry site in frog skin epithelium.', 'publication_year': 1981, 'publication_date': '1981-11-01', 'ids': {'openalex': 'https://openalex.org/W2258666746', 'mag': '2258666746', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/6974777'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/6974777', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5034828507', 'display_name': 'D. J. Benos', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'D J Benos', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5036151822', 'display_name': 'Jeffrey W. H. Watthey', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'J W Watthey', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.361, 'has_fulltext': False, 'cited_by_count': 12, 'citation_normalized_percentile': {'value': 0.543091, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 82, 'max': 83}, 'biblio': {'volume': '219', 'issue': '2', 'first_page': '481', 'last_page': '8'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11178', 'display_name': 'Receptor Mechanisms and Signaling', 'score': 0.9597, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11178', 'display_name': 'Receptor Mechanisms and Signaling', 'score': 0.9597, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10056', 'display_name': 'Neurotransmitter Receptor Influence on Behavior', 'score': 0.9162, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/amiloride', 'display_name': 'Amiloride', 'score': 0.9661682}, {'id': 'https://openalex.org/keywords/frog-skin', 'display_name': 'Frog Skin', 'score': 0.91874665}, {'id': 'https://openalex.org/keywords/epithelial-sodium-channel', 'display_name': 'Epithelial sodium channel', 'score': 0.50899124}, {'id': 'https://openalex.org/keywords/pyrazine', 'display_name': 'Pyrazine', 'score': 0.4376167}], 'concepts': [{'id': 'https://openalex.org/C2779608910', 'wikidata': 'https://www.wikidata.org/wiki/Q419995', 'display_name': 'Amiloride', 'level': 3, 'score': 0.9661682}, {'id': 'https://openalex.org/C2777103240', 'wikidata': 'https://www.wikidata.org/wiki/Q18356482', 'display_name': 'Frog Skin', 'level': 3, 'score': 0.91874665}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.5560964}, {'id': 'https://openalex.org/C6507245', 'wikidata': 'https://www.wikidata.org/wiki/Q424948', 'display_name': 'Epithelial sodium channel', 'level': 3, 'score': 0.50899124}, {'id': 'https://openalex.org/C17077164', 'wikidata': 'https://www.wikidata.org/wiki/Q1185869', 'display_name': 'Inhibitory postsynaptic potential', 'level': 2, 'score': 0.49942493}, {'id': 'https://openalex.org/C537181965', 'wikidata': 'https://www.wikidata.org/wiki/Q658', 'display_name': 'Sodium', 'level': 2, 'score': 0.4670388}, {'id': 'https://openalex.org/C2777765701', 'wikidata': 'https://www.wikidata.org/wiki/Q424284', 'display_name': 'Pyrazine', 'level': 2, 'score': 0.4376167}, {'id': 'https://openalex.org/C12554922', 'wikidata': 'https://www.wikidata.org/wiki/Q7100', 'display_name': 'Biophysics', 'level': 1, 'score': 0.42666078}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.42131278}, {'id': 'https://openalex.org/C24998067', 'wikidata': 'https://www.wikidata.org/wiki/Q4114622', 'display_name': 'Stimulation', 'level': 2, 'score': 0.418933}, {'id': 'https://openalex.org/C71240020', 'wikidata': 'https://www.wikidata.org/wiki/Q186011', 'display_name': 'Stereochemistry', 'level': 1, 'score': 0.32869166}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.30932274}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.275245}, {'id': 'https://openalex.org/C178790620', 'wikidata': 'https://www.wikidata.org/wiki/Q11351', 'display_name': 'Organic chemistry', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D012867', 'descriptor_name': 'Skin', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D012964', 'descriptor_name': 'Sodium', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D000584', 'descriptor_name': 'Amiloride', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000584', 'descriptor_name': 'Amiloride', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000584', 'descriptor_name': 'Amiloride', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001562', 'descriptor_name': 'Benzimidazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001562', 'descriptor_name': 'Benzimidazoles', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D001692', 'descriptor_name': 'Biological Transport', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001692', 'descriptor_name': 'Biological Transport', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D004848', 'descriptor_name': 'Epithelium', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004848', 'descriptor_name': 'Epithelium', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D004848', 'descriptor_name': 'Epithelium', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D066298', 'descriptor_name': 'In Vitro Techniques', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010069', 'descriptor_name': 'Oxadiazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010069', 'descriptor_name': 'Oxadiazoles', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D011892', 'descriptor_name': 'Rana catesbeiana', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012867', 'descriptor_name': 'Skin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012867', 'descriptor_name': 'Skin', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D012964', 'descriptor_name': 'Sodium', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013329', 'descriptor_name': 'Structure-Activity Relationship', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/6974777', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2332135117', 'https://openalex.org/W2229655342', 'https://openalex.org/W2207281967', 'https://openalex.org/W2140942336', 'https://openalex.org/W2088462076', 'https://openalex.org/W206794969', 'https://openalex.org/W2045134416', 'https://openalex.org/W2044992039', 'https://openalex.org/W2033970084', 'https://openalex.org/W2009950228'], 'abstract_inverted_index': {'The': [0, 40], 'inhibition': [1, 100], 'and': [2, 62, 94, 106, 113, 133], 'stimulation': [3], 'of': [4, 15, 18, 29, 43, 54, 103], 'short-circuit': [5, 111], 'current': [6, 112], 'in': [7, 8, 78], 'vitro': [9], 'frog': [10, 79], 'skin': [11], 'by': [12], 'a': [13, 30], 'series': [14], 'structural': [16], 'analogs': [17], 'the': [19, 26, 50, 59, 63, 85, 99, 124, 144], 'diuretic': [20], 'drug': [21], 'amiloride': [22, 48], 'were': [23], 'studied.': [24], 'Also,': [25], 'inhibitory': [27, 131], 'profile': [28], 'new': [31], 'experimental': [32], 'diuretic,': [33], '3-(3-amino-1,2,4-oxadiazol-5-yl)-5-chloro-2,6-pyrazinediamine,': [34], 'or': [35], 'CGS': [36, 72], '4270,': [37], 'was': [38], 'determined.': [39], 'major': [41], 'conclusions': [42], 'our': [44], 'studies': [45], 'are:': [46], '1)': [47], 'remains': [49], 'most': [51], 'effective': [52], 'inhibitor': [53], 'Na+': [55, 76, 93, 126, 138], 'entry,': [56], 'with': [57, 92, 97, 118], 'both': [58], 'pyrazine': [60], 'ring': [61], 'acylguanidine': [64], 'moiety': [65], 'being': [66], 'required': [67], 'for': [68], 'maximum': [69], 'activity;': [70], '2)': [71], '4270': [73], 'also': [74, 141], 'inhibits': [75], 'transport': [77], 'skin;': [80], 'it': [81], 'acts': [82], 'only': [83], 'from': [84], 'external': [86, 104], 'solution,': [87], 'is': [88, 90, 101, 116], 'uncharged,': [89], 'noncompetitive': [91], 'interacts': [95], 'noncompetitively': [96], 'amiloride;': [98], 'independent': [102], 'calcium;': [105], '3)': [107], 'benzimidazole': [108], 'increases': [109], 'amiloride-sensitive': [110], 'this': [114], 'compound': [115], 'competitive': [117], 'amiloride.': [119], 'These': [120], 'results': [121], 'indicate': [122], 'that': [123, 134], 'putative': [125], 'entry': [127, 139], 'protein': [128], 'contains': [129], 'multiple': [130], 'sites': [132], 'compounds': [135], 'which': [136], 'stimulate': [137], 'may': [140], 'bind': [142], 'at': [143], 'same': [145], 'molecular': [146], 'locus': [147], 'as': [148], 'an': [149], 'inhibitor.': [150]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2258666746', 'counts_by_year': [], 'updated_date': '2024-12-17T02:34:16.260618', 'created_date': '2016-06-24'}